IP Library › Assignment 029785/0460
Patent Assignment
Reel/Frame 029785/0460

Assignment of Assignor's Interest

Recorded: 2013-02-09 Pages: 13
Assignor
DOGWOOD PHARMACEUTICALS, INC.
Executed: 2012-12-21
Assignee
ADENOSINE THERAPEUTICS, LLC
1670 DISCOVERY DRIVE, SUITE 212, CHARLOTTESVILLE, VIRGINIA, 22911
Covered Properties (56)
Methods for Preparing 2-Alkynyladenosine Derivatives
Selective Antagonists of A2A Adenosine Receptors
Pyridyl Substituted Xanthines
Derivatives of 8-Substituted Xanthines
Pyrazolyl Substituted Xanthines
Substituted Aryl Piperidinylalkynyladenosines as A2AR Agonists
Selective Antagonists of A2A Adenosine Receptors
Pyrrolo[3,2-D]Pyrimidines That Are Selective Antagonists of A2B Adenosine Receptors
Adenosine Derivative Formulations for Medical Imaging
Agonists of A2A Adenosine Receptors for Treating Recurrent Tumor Growth in the Liver Following Resection
Substituted 4-{3-[6-Amino-9-(3, 4-Dihydroxy-Tetrahydro-Furan-2-Yl)-9H-Purin-2-Yl]-Prop-2-Ynyl}-Piperidine-1-Carboxylic Acid Esters as A2AR Agonists
Intrathecal Treatment of Neuropathic Pain with A2AR Agonists
Alkoxy-Carbonyl-Amino-Alkynyl-Adenosine Compounds and Derivatives Thereof as A2A Agonists
Methods for preparing 2-alkynyladenosine derivatives
Application: 10/848,403 →
Publication: US 2005/0033044
Selective Antagonists of A2A Adenosine Receptors
Patent: 7,217,702 →
Application: 11/097,251 →
Publication: US 2005/0282831
Pyridyl Substituted Xanthines
Patent: 7,601,723 →
Application: 11/362,387 →
Publication: US 2007/0072843
Derivatives of 8-Substituted Xanthines
Patent: 7,579,348 →
Application: 11/362,392 →
Publication: US 2007/0249598
Pyrazolyl Substituted Xanthines
Patent: 7,618,962 →
Application: 11/362,393 →
Publication: US 2007/0066631
Methods for the synthesis of substituted amino uracils
Application: 11/510,632 →
Publication: US 2007/0049757
Selective antagonists of A2A adenosine receptors
Application: 11/803,312 →
Publication: US 2007/0244134
Substituted Aryl Piperidinylalkynyladenosines as A2AR Agonists
Patent: 7,589,076 →
Application: 11/804,165 →
Publication: US 2007/0270373
Selective Antagonists of A2A Adenosine Receptors
Patent: 7,985,754 →
Application: 11/879,133 →
Publication: US 2009/0118309
Pyrrolo[3,2-D] Pyrimidines That Are Selective Antagonists of A2BADENOSINE Receptors
Patent: 7,470,697 →
Application: 11/897,678 →
Publication: US 2008/0125425
Methods for Preparing 2-Alkynyladenosine Deriviatives
Patent: 7,671,191 →
Application: 11/975,080 →
Publication: US 2008/0177055
Adenosine Derivative Formulations for Medical Imaging
Application: 12/014,949 →
Publication: US 2008/0219927
Selective Antagonists of A2A Adenosine Receptors
Application: 12/049,801 →
Publication: US 2008/0176858
Agonists of A2A Adenosine Receptors for Treating Recurrent Tumor Growth in the Liver Following Resection
Application: 12/102,185 →
Publication: US 2008/0262001
Pyrrolo[3,2-D]Pyrimidines That Are Selective Antagonists of A2B Adenosine Receptors
Patent: 8,349,848 →
Application: 12/266,259 →
Publication: US 2009/0082347
Substituted 8-[6-Amino-3PYRIDYL]Xanthines
Patent: 7,875,608 →
Application: 12/337,010 →
Publication: US 2009/0163491
Substituted 4-{3-[6-Amino-9-(3, 4-Dihydroxy-Tetrahydro-Furan-2-Yl)-9H-Purin-2-Yl]-Prop-2-Ynyl}-Piperidine-1-Carboxylic Acid Esters as A2AR Agonists
Patent: 8,293,720 →
Application: 12/338,369 →
Publication: US 2009/0162292
Intrathecal Treatment of Neuropathic Pain with A2AR Agonists
Application: 12/351,209 →
Publication: US 2009/0181920
Substituted Aryl Piperidinylalkynyladenosines as A2AR Agonists
Patent: 7,888,329 →
Application: 12/501,750 →
Publication: US 2009/0280059
Pyrazolyl Substituted Xanthines
Patent: 8,153,628 →
Application: 12/507,472 →
Publication: US 2010/0120765
Substituted 4-{3-[6-Amino-9-(3, 4-Dihydroxy-Tetrahydro-Furan-2-Yl)-9H-Purin-2-Yl]-Prop-2-Ynyl}-Piperidine-1-Carboxylic Acid Esters as A2AR Agonists
Patent: 8,252,767 →
Application: 12/809,381 →
Publication: US 2011/0003765
Alkoxy-Carbonyl-Amino-Alkynyl-Adenosine Compounds and Derivatives Thereof as A2AR Agonists
Patent: 8,263,762 →
Application: 12/827,932 →
Publication: US 2011/0003766
Agonists of A2A Adenosine Receptors for Treating Recurrent Tumor Growth
Patent: 8,551,972 →
Application: 12/940,457 →
Publication: US 2011/0166094
Substituted Aryl Piperidinylalkynyladenosines as A2AR Agonists
Patent: 8,222,228 →
Application: 12/981,308 →
Publication: US 2011/0091385
Selective Antagonists of A2A Adenosine Receptors
Application: 13/190,136 →
Publication: US 2012/0035192
Selective Antagonists of A2A Adenosine Receptors
Application: 13/587,275 →
Publication: US 2012/0309774
Adenosine Derivative Formulations for Medical Imaging
Patent: 9,555,129 →
Application: 13/615,760 →
Publication: US 2013/0004426
Methods for preparing 2-alkynladenosine derivatives
Application: 60/471,643 →
Selective antagonists of A2A adenosine receptors
Application: 60/559,159 →
Derivatives of 8-substituted xanthines
Application: 60/656,086 →
Pyridyl substituted xanthines
Application: 60/656,087 →
Pyrazolyl substituted xanthines
Application: 60/656,105 →
Methods for the synthesis of substituted amino uracils
Application: 60/711,422 →
Substituted Aryl Piperidinylalkynyladenosines as A2AR Agonists
Application: 60/747,625 →
Selective Antagonists of A2A Adenosine Receptors
Application: 60/807,545 →
Selective Antagonists of A2B Adenosine Receptors
Application: 60/824,316 →
Adenosine Derivative Formulations for Medical Imaging
Application: 60/885,489 →
Agonists of A2A adenosine receptors for treating recurrent tumor growth in the liver following resection
Application: 60/925,736 →
Substituted 8-[6-Amino-3-Pyridyl]Xanthines
Application: 61/014,134 →
Substituted 4-{3-[6-Amino-9-(3, 4-Dihydroxy-Tetrahydro-Furan-2-Yl)-9H-Purin-2-Yl]-Prop-2-Ynyl}-Piperidine-1-Carboxylic Acid Esters as A2AR Agonists
Application: 61/015,303 →
Intrathecal Treatment of Neuropathic Pain with A2AR Agonists
Application: 61/019,912 →
Alkoxy-Carbonyl-Amino-Alkynyl-Adenosine Compounds and Derivatives Thereof as A2AR Agonists
Application: 61/221,692 →
Substituted 8-[6-Carbonylamine-3-Pyridyl]Xanthines
Application: 61/223,474 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 27, 2004
From: PICKERSGILL, IAIN F.; CHEESMAN, EDWARD H.
To: BRISTOL-MYERS SQUIBB PHARMA COMPANY
Reel/Frame 015089/0066 →
Assignment of Assignor's Interest Sep 2, 2005
From: BEAUGLEHOLE, ANTHONY; RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 016487/0660 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0139 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0129 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0328 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0204 →
Assignment of Assignor's Interest May 22, 2007
From: BRISTOL-MYERS SQUIBB PHARMA COMPANY
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019330/0287 →
Assignment of Assignor's Interest Jul 12, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019555/0937 →
Assignment of Assignor's Interest Mar 26, 2008
From: WANG, GUOQUAN; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 020708/0784 →
Assignment of Assignor's Interest Aug 12, 2008
From: BEAUGLEHOLE, ANTHONY; REIGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 021377/0599 →
Assignment of Assignor's Interest Jan 8, 2009
From: ADENOSINE THERAPEUTICS, LLC
To: PGXHEALTH, LLC
Reel/Frame 022075/0734 →
Assignment of Assignor's Interest Apr 20, 2009
From: KRANENBURG, ONNO; VAN DER BILT, JARMILA; RINKES, INNE BOREL; RIEGER, JAYSON M
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 022568/0395 →
Assignment of Assignor's Interest Apr 20, 2009
From: ADENOSINE THERAPEUTICS
To: PGXHEALTH, LLC
Reel/Frame 022568/0447 →
Change of Name Jan 28, 2011
From: PGXHEALTH, LLC
To: TROVIS PHARMACEUTICALS, LLC
Reel/Frame 025710/0370 →
Change of Name Jan 28, 2011
From: PGXHEALTH, LLC
To: TROVIS PHARMACEUTICALS, LLC
Reel/Frame 025709/0994 →
Assignment of Assignor's Interest Jun 7, 2011
From: WANG, GUOQUAN; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS LLC
Reel/Frame 026400/0078 →
Merger Dec 14, 2011
From: TROVIS PHARMACEUTICALS LLC
To: TROVIS PHARMACEUTICALS HOLDINGS, INC.
Reel/Frame 027386/0851 →
Assignment of Assignor's Interest Dec 14, 2011
From: CLINICAL DATA, INC.
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 027386/0502 →
Assignment of Assignor's Interest Dec 14, 2011
From: DOGWOOD PHARMACEUTICALS, INC.
To: FOREST LABORATORIES HOLDINGS LIMITED
Reel/Frame 027386/0509 →
Merger Dec 14, 2011
From: TROVIS PHARMACEUTICALS HOLDINGS, INC.
To: CLINICAL DATA, INC.
Reel/Frame 027386/0494 →
Merger Jan 9, 2012
From: TROVIS PHARMACEUTICALS HOLDINGS, INC.
To: CLINICAL DATA, INC.
Reel/Frame 027499/0196 →
Assignment of Assignor's Interest Jan 9, 2012
From: DOGWOOD PHARMACEUTICALS, INC.
To: FOREST LABORATORIES HOLDINGS LIMITED
Reel/Frame 027499/0300 →
Assignment of Assignor's Interest Jan 9, 2012
From: CLINICAL DATA, INC.
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 027499/0253 →
Merger Jan 9, 2012
From: TROVIS PHARMACEUTICALS LLC
To: TROVIS PHARMACEUTICALS HOLDINGS, INC.
Reel/Frame 027499/0121 →
Merger Jan 24, 2013
From: TROVIS PHARMACEUTICALS LLC
To: TROVIS PHARMACEUTICALS HOLDINGS, INC.
Reel/Frame 029688/0503 →